Elecsys Anti-Tg
System, Test, Thyroid Autoantibody. 510(k) K222610, from Roche Diagnostics (Indianapolis, IN). Product code JZO, class 2.
As of Nov 22, 2026, K222610 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Sep 15, 2023 after 382 days, with no recalls tied to it in FDA's recall database.
- Review time: 382 days
- Recalls: 0
Immunoassay for the in vitro quantitative determination of antibodies to thyroglobulin in human serum and plasma. The anti‑Tg autoantibodies determination is used as an aid in the detection of autoimmune thyroid diseases in conjunction with other laboratory and clinical findings. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 411 immunoassay analyzer.
- Roche Elecsys Anti-TgK053426 · Roche Diagnostics Corp. · Feb 7, 2006
- ADVIA Centaur Anti-Thyroid Peroxidase IIK250250 · Siemens Healthcare Diagnostics, Inc. · Oct 17, 2025
- Access TPO AntibodyK240469 · Beckman Coulter, Inc. · Aug 9, 2024
- Access Thyroglobulin Antibody IIK213517 · Beckman Coulter, Inc. · Sep 26, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 29, 2022
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5870
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files